文献速递肝病

老年人非酒精性脂肪性肝病的沉默负担:全球疾病负担分析

The silent burden of non-alcoholic fatty liver disease in the elderly: A global burden of disease analysis.
PubMed 文献 · Aliment Pharmacol Ther · 2023-09-11

基于2010至2019年全球疾病负担研究数据,分析65至89岁老年人非酒精性脂肪性肝病的患病率、死亡率和伤残调整寿命年。

要点

  • 西太平洋地区老年人非酒精性脂肪性肝病负担最高,年变化百分比+0.95%(p<0.001)。
  • 男性患病率增长(年变化百分比+0.74%)快于女性(+0.63%),美洲死亡和伤残调整寿命年率略增。

核心结论

  • 过去十年老年人非酒精性脂肪性肝病负担持续增加,需要立即采取包容性措施应对。

研究设计与样本

  • 利用2010至2019年全球疾病负担研究数据,按地区、国家、社会人口指数和性别分层,分析65至89岁老年人非酒精性脂肪性肝病的患病率、死亡率和伤残调整寿命年。

主要发现

  • 西太平洋地区老年人非酒精性脂肪性肝病负担最高。
  • 2010至2019年所有地区患病率均上升,西太平洋地区年变化百分比+0.95%(p<0.001)。
  • 男性患病率年变化百分比+0.74%(p<0.001),女性+0.63%(p<0.001)。
  • 多数地区死亡率和伤残调整寿命年率下降,美洲例外,分别略增年变化百分比+0.25%(p=0.002)和+0.38%(p<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) represents a significant health threat worldwide. The growing trend towards an aging population, along with an alarming rise in obesity and diabetes, may have significant implications for the burden of NAFLD. AIM: To assess the impact of NAFLD on the elderly. METHODS: We utilised data from the Global Burden of Disease study between 2010 and 2019 to conduct a comprehensive analysis of the prevalence, mortality, and disability-adjusted life years (DALYs) associated with NAFLD in the elderly (65-89 years), stratified by region, nation, sociodemographic Index and sex. RESULTS: Globally, there were an estimated 228 million cases, 87,230 deaths and 1.46 million DALYs attributed to NAFLD in the elderly. Geographically, the Western Pacific region had the highest burden of NAFLD in the elderly. From 2010 to 2019, there was an increasing prevalence rate in all areas, with the most pronounced change observed in the Western Pacific region (annual percentage change (APC) +0.95%, p < 0.001). Over the study period, there was a more rapid increase in NAFLD prevalence in men (APC +0.74%, p < 0.001) than in women (APC +0.63%, p < 0.001). In most regions, death and DALYs rates have declined, with the exception of the Americas, where there was a slight increase (APC +0.25%, p = 0.002 and 0.38%, p < 0.001, respectively). CONCLUSION: Over the past decade, the burden of NAFLD in the elderly has been increasing, necessitating immediate and inclusive measures to tackle the rising burden.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Danpanichkul P, Ng CH, Muthiah MD, et al. The silent burden of non-alcoholic fatty liver disease in the elderly: A global burden of disease analysis. Aliment Pharmacol Ther. 2023. PMID: 37694808. doi:10.1111/apt.17714

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。